Guangzheng Deng
Overview
Explore the profile of Guangzheng Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheung J, Deng G, Wong N, Dong Y, Ng S
Front Cell Dev Biol
. 2022 Sep;
10:982606.
PMID: 36172270
Beyond transcription, RNA molecules are enzymatically modified to influence the biological functions of living organisms. The term "epitranscriptomics" describes the changes in RNA strands aside from altering the innate sequences....
2.
Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, et al.
EMBO Mol Med
. 2022 Mar;
14(3):e15618.
PMID: 35253379
No abstract available.
3.
Liu Q, He L, Li S, Li F, Deng G, Huang X, et al.
J Hematol Oncol
. 2021 Jan;
14(1):6.
PMID: 33407765
Background: HOMER family scaffolding proteins (HOMER1-3) play critical roles in the development and progression of human disease by regulating the assembly of signal transduction complexes in response to extrinsic stimuli....
4.
Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, et al.
EMBO Mol Med
. 2019 Oct;
11(12):e10638.
PMID: 31657150
Resistance to tamoxifen is a clinically major challenge in breast cancer treatment. Although downregulation of estrogen receptor-alpha (ERα) is the dominant mechanism of tamoxifen resistance, the reason for ERα decrease...
5.
Xiong Z, Deng G, Wang J, Li X, Xie X, Shuang Z, et al.
BMC Cancer
. 2018 Sep;
18(1):885.
PMID: 30200932
Background: Resection of the primary tumor is recommended for symptom relief in de novo stage IV breast cancer. We explored whether local surgery could provide a survival benefit in these...
6.
Xiong Z, Yang L, Deng G, Huang X, Li X, Xie X, et al.
J Clin Med
. 2018 Jun;
7(6).
PMID: 29857526
Population-based estimates are lacking for the temporal trends in the contralateral breast cancer (CBC) risk for patients with breast cancer (BC). Data for BC patients diagnosed with CBC were collected...
7.
Xiong Z, Ye L, Zhenyu H, Li F, Xiong Y, Lin C, et al.
Mol Oncol
. 2018 Apr;
12(6):896-912.
PMID: 29633513
Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor, and the HER2 receptor; it is highly proliferative and becomes the deadliest forms of breast cancer. Effective prognostic...
8.
Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, et al.
Cancer Manag Res
. 2018 Feb;
10:287-295.
PMID: 29467583
Purpose: Bone is one of the most common sites of breast cancer metastasis, and population-based studies of patients with bone metastasis in initial metastatic breast cancer (MBC) are lacking. Materials...
9.
Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, et al.
Cancer Res Treat
. 2018 Jan;
50(4):1260-1269.
PMID: 29334609
Purpose: Survival of metastatic breast cancer (MBC) patient remains unknown and varies greatly from person to person. Thus, we aimed to construct a nomogram to quantify the survival probability of...